What's new

Human medicines European public assessment report (EPAR): Opfolda, miglustat, Date of authorisation: 26/06/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Opfolda, miglustat, Date of authorisation: 26/06/2023, Revision: 3, Status: Authorised

Feb 14, 2025 - 14:10
 0
Human medicines European public assessment report (EPAR): Opfolda, miglustat, Date of authorisation: 26/06/2023, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Opfolda, miglustat, Date of authorisation: 26/06/2023, Revision: 3, Status: Authorised
Read More

Tags:

Previous Article

‘Road map’ outlining how cancers spread offers hope for new treatments

Next Article

Emerging British designers look to Paris for growth as London Show Rooms returns...

Related Posts

Agenda - ACT EU workshop on ICH E6 (R3)

Feb 18, 2025  0

CTIS newsflash - 11 March 2025

Mar 12, 2025  0

Human medicines European public assessment report (EPAR): Balversa, Erdafitinib, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 19, 2025  0